Glenmark Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
3,473.21
3,275.68
3,836.12
2,552.11
3,209.08
Other Income Qtr Cr39.4231.49773.1645.411.70
Operating Revenues Qtr3,433.803,244.193,062.952,506.703,207.38

*All values are in Cr.

Operating Expenses Qtr
2,831.88
2,655.97
2,558.61
2,715.35
2,745.09
Operating Profit Qtr
601.91
588.21
504.34
-208.65
462.28
EBIDT Qtr Cr
641.33
619.70
855.10
-121.20
257.30
Depreciation Qtr
120.28
117.79
151.34
147.08
141.45
Net Profit Qtr
354.21
340.27
-1,218.28
-351.38
-81.94
Basic EPS Qtr
12.55
12.06
-43.18
-12.45
-2.90
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -